Pharmacoeconomic Aspects of the First-Line Biologic Therapies in Russian Patients with Rheumatoid Arthritis
Nov 1, 2013, 00:00 AM
10.1016/j.jval.2013.08.1494
https://www.valueinhealthjournal.com/article/S1098-3015(13)03399-8/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1334
First Page :
A563
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03399-8&doi=10.1016/j.jval.2013.08.1494